Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
07/2003
07/31/2003WO2002051410A3 Phenylthiazole and thiazoline derivatives and their use as antiparasitics
07/31/2003WO2002040471A9 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
07/31/2003WO2002020500A3 Materials and methods to potentiate cancer treatment
07/31/2003US20030144533 Synthetic intermediate for epothilone derivative and production method thereof
07/31/2003US20030144523 Epothilone derivatives, method for producing same and their pharmaceutical use
07/31/2003US20030144507 Sulfonamide-containing heterocyclic compounds
07/31/2003US20030144506 Formula 1 are useful in treating abnormal cell growth in mammals by administering pharmaceutical compositions.
07/31/2003US20030144504 Dialkyl-halogenophenyl-substituted ketoenols
07/31/2003US20030144330 Peroxidase proliferator activated receptor (PPAR) gamma agonists for playing key role in inducing growth arrest by terminal differentiation of actively proliferating PPAR gamma-expressing cells, particularly transformed adipose cells
07/31/2003US20030144329 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases
07/31/2003US20030144328 Compounds which inhibit leukocyte adhesion mediated by VLA-4
07/31/2003US20030144326 Cyclic amine phenyl beta-3 adrenergic receptor agonists
07/31/2003US20030144320 For treatment and/or prevention of anxiety, mania, depression, panic disorders, nerve sustem disorders
07/31/2003US20030144309 Inhibitors of Src and other protein kinases
07/31/2003US20030144308 Fructose 1,6-bisphosphatase inhibitors
07/31/2003US20030144303 Aminopyrimidine and aminopyridine anti-inflammation agents
07/31/2003US20030144300 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
07/31/2003US20030144288 Sulfur compounds such as 4-fluoro-N-(4-methoxy-7-(tetrahydro-pyran-4-yl)-benzothiazol-2-yl) -benzamide, used as preferential adenosine receptor ligands for the prophylaxis of neurodegenerative disorders
07/31/2003US20030144282 Inhibitors of cytosolic phospholipase A2
07/31/2003US20030144280 Heterocyclic imines, used as cyclooxygenase inhibitors, administered as inflammatory and pain relievers in disorders such as arthritis, neurodegeneration or cancer in mammals
07/31/2003US20030144277 Piperizinones as modulators of chemokine receptor activity
07/31/2003US20030144276 Heterocycle-containing carboxylic acid derivative and drug containing the same
07/31/2003US20030144263 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
07/31/2003US20030144250 Triazole derivatives useful in therapy
07/31/2003US20030144175 Protease inhibitors
07/31/2003CA2474322A1 4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2
07/31/2003CA2473796A1 Substituted quinazolin-4-ylamine analogues
07/31/2003CA2473508A1 Pyrimidinone viral polymerase inhibitors
07/31/2003CA2471989A1 2-aminothiazole allosteric enhancers of a1 adenosine receptors
07/30/2003EP1331224A1 Thiazole or oxazole derivatives
07/30/2003EP1330452A2 Pyrazine derivatives as modulators of tyrosine kinases
07/30/2003EP1330451A2 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators
07/30/2003EP1330448A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders
07/30/2003EP1330446A1 Process for the manufacture of thiazole derivatives with pesticidal activity
07/30/2003EP1330442A1 Phthalazinone derivatives
07/30/2003EP1173435B1 Polymorph of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
07/30/2003EP1123287B1 Insecticidal 3- (substituted pyridyl) -1, 2, 4-triazoles
07/30/2003EP0991428B1 Delta1,2 bicyclo 4,4,0] functional dyes for contrast enhancement in optical imaging
07/30/2003EP0958296B1 Heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
07/30/2003EP0835252B1 Triazole antifungal agents
07/30/2003CN1433416A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamideinhibitors of cyclin dependent kinases
07/30/2003CN1433415A N-[5-[[[5-alkyl-2-oxazlyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
07/30/2003CN1433414A Benzazole derivatives and their use as JNK modulators
07/30/2003CN1433411A Chemical compounds
07/30/2003CN1433410A CDK inhibitors having 3-hydroxychromen-4-one structure
07/30/2003CN1433408A Aminothiazole inhibitors of cyslin dependent kinases
07/30/2003CN1433405A Quinazoline compounds
07/30/2003CN1433402A Cycloamine CCR5 receptor antagonists
07/30/2003CN1116366C Pyridone-methide azo dyestuffs
07/29/2003US6600043 Carboxylic acid derivatives, their preparation and use
07/29/2003US6599926 Anticoagulant agents for treatment and prevention of thromboembolic disorders
07/29/2003US6599924 2-hetaryl-3,4 dihydro-2H-pyrrole pesticide
07/29/2003US6599901 Pyridone substituted benzothiazole derivatives
07/29/2003CA2124584C Tetrahydropyridine derivative and cardiotonic agent containing the same as effective component
07/29/2003CA2066332C Substituted 3-(pyridinylamino)-indoles and benzo¬b|thiophenes, a process for their preparation and their use as medicaments
07/24/2003WO2003060078A2 Heterocyclic modulators of nuclear receptors
07/24/2003WO2003059908A1 Novel thioester derivatives and process for preparation of cephalosporin
07/24/2003WO2003059903A2 Substituted 4-aminopyridine derivatives used as pest control agents
07/24/2003WO2003059897A1 Thiadiazole compounds and use thereof
07/24/2003WO2003059894A1 Novel antibacterial compounds:process for their preparation and pharmaceutical compositions containing them.
07/24/2003WO2003059891A1 Substituted pyridazinones as inhibitors of p38
07/24/2003WO2003059884A1 Modulators of lxr
07/24/2003WO2003059881A2 Dna minor groove binding compounds
07/24/2003WO2003059873A1 Potassium channel modulators
07/24/2003WO2003059341A1 1,3-disubstituted and 1,3,3,-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
07/24/2003WO2003059289A2 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
07/24/2003WO2003059269A2 Acridone inhibitors of impdh enzyme
07/24/2003WO2003059265A2 Compositions and methods for treating heart failure
07/24/2003WO2003059064A1 Insecticides containing hydrazone derivatives as the active ingredient and novel hydrazone derivatives
07/24/2003WO2003047577A3 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
07/24/2003US20030139604 Solid state nuclear magnetic resonance spectrum, phase shifting, infrared spectrum analysis; treating prophylaxis of diabetes mellitus
07/24/2003US20030139603 Pioglitazone hydrochloride
07/24/2003US20030139597 Novel Cyclic hydroxamic acid as metalloproteinase inhibitors
07/24/2003US20030139460 Antitumor, anticancer agents; antiinflammatory agents; psoriasis; antiarthritic agents; side effect reduction
07/24/2003US20030139447 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
07/24/2003US20030139406 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators
07/24/2003US20030139404 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
07/24/2003US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders
07/24/2003US20030139393 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
07/24/2003US20030139388 Antiinflammatory agents; osteoporosis
07/24/2003US20030139379 Autoimmune disease, osteoporosis, rheumatic diseases, skin disorders
07/24/2003US20030138664 Light emitting device material, light emitting device using thereof, and amine compound
07/24/2003CA2474239A1 Substituted pyridazinones as inhibitors of p38
07/24/2003CA2472470A1 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
07/24/2003CA2472469A1 1,3-disubstituted and 1,3,3,-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
07/24/2003CA2469435A1 Modulators of lxr
07/23/2003EP1329450A1 Benzodiazepine derivative
07/23/2003EP1329218A1 Preventives/remedies for portal hypertension
07/23/2003EP1328514A1 Amide derivatives as nmda receptor antagonists
07/23/2003EP1328512A2 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists
07/23/2003EP1187819B1 N-substituted perhydro diazine
07/23/2003EP0984688B1 Fungicidal mixtures
07/23/2003EP0929528B1 Aralkyl and aralkylidene heterocyclic lactams and imides
07/23/2003EP0695183B1 Use of thiazolidinediones for the treatment of atherosclerosis and eating disorders
07/23/2003CN1432015A Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation
07/23/2003CN1432014A Triazole compounds having amide linkage
07/23/2003CN1432011A Benzoamide piperidine compounds as substance P antagonists
07/23/2003CN1432009A Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain
07/23/2003CN1432004A Alkynyl phenyl heteroaromatic glucokinase activators
07/23/2003CN1432000A TNF-alpha prodn. inhibitors
1 ... 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 ... 628